Morning Bid: RBA decides, debate sparks over China policy shift
By Jamie McGeever (Reuters) - A look at the day ahead in Asian markets. The Reserve Bank of Australia's interest rate decision takes center stage on Tuesday, while debate...
Kinder Morgan forecasts higher profit in 2025
(Reuters) -Kinder Morgan forecast higher earnings for 2025 on Monday as the U.S. pipeline operator bets on growth in its natural gas pipelines and energy transition ventures amid...
C3.ai lifts annual forecast on strong demand for enterprise AI software
(Reuters) -C3.ai raised its forecast for fiscal year 2025 revenue on Monday, helped by healthy demand for the company's enterprise artificial intelligence software as companies...
To help abuse survivors, Biden watchdog launches rulemaking
(Reuters) - The U.S. watchdog for consumer finance on Monday announced the start of the rulemaking process to protect victims of domestic violence and elder abuse, saying those...
Factbox-What is the UnitedHealthcare business that was led by slain CEO Brian Thompson?
By Michael Erman NEW YORK (Reuters) -Brian Thompson, the CEO of UnitedHealth's insurance unit, was fatally shot in midtown Manhattan last week in what police described as a...
Colombia's interior minister says proposed $2.73 billion fiscal reform not viable
BOGOTA (Reuters) - Colombia's Interior Minister Juan Fernando Cristo on Monday said the government's proposed 12 trillion peso ($2.73 billion) fiscal reform was "not viable," but...
Canadian government to present mini budget on Dec. 16
By Ismail Shakil OTTAWA (Reuters) - The Canadian government will present its fall economic statement on Dec. 16, the finance ministry said on Monday, announcing a date for the...
Fed likely to cut rates next week, but outlook to tilt hawkish: Macquarie
-- The Federal Reserve is likely to cut rates next week, but a slew of data pointing to a still strong labor market and slowing disinflation will force the Fed's...
Citigroup joins Wall Street peers in forecasting 25 bps rate cut by Fed in December
(Reuters) - Citigroup (NYSE:C), previously the only Wall Street brokerage forecasting a 50 basis point rate cut by the U.S. Federal Reserve, has now aligned with its peers in...
Revance agrees to lower take-private offer by Crown Labs
(Reuters) -Crown Laboratories would buy the anti-wrinkle injection maker Revance Therapeutics (NASDAQ:RVNC) at a roughly 50% lower price compared to an original agreement signed...